Cargando…

Brugada syndrome in a young patient with type 1 myotonic dystrophy requiring an implantable cardioverter defibrillator for primary prevention: a case report

BACKGROUND : Cardiac electrical disturbances represent the most frequent cardiac manifestations of myotonic dystrophy Type 1 (MD1). Limited data suggest that the prevalence of Brugada syndrome in MD1 may be increased compared to the general population. CASE SUMMARY : We report a case of a 22-year-ol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Korantzopoulos, Panagiotis, Bechlioulis, Aris, Lakkas, Lampros, Naka, Katerina K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6601169/ https://www.ncbi.nlm.nih.gov/pubmed/31449644 http://dx.doi.org/10.1093/ehjcr/ytz086

Ejemplares similares

A Case of Young Brugada Syndrome Patient With Implantable Cardioverter Defibrillator Complication Requiring Device Extraction and Reimplantation
por: Khan, Zahid
Publicado: (2023)

Prognosis after Implantation of Cardioverter-Defibrillators in Korean Patients with Brugada Syndrome
por: Son, Myoung Kyun, et al.
Publicado: (2014)

Implantable cardioverter‐defibrillator in Brugada syndrome: Long‐term follow‐up
por: El‐Battrawy, Ibrahim, et al.
Publicado: (2019)

Inappropriate implantable cardioverter-defibrillator shocks in Brugada syndrome: Pattern in primary and secondary prevention
por: Bonny, Aimé, et al.
Publicado: (2016)

Subcutaneous implantable cardioverter-defibrillator implantation assisted by hypnotic communication in a patient with Brugada syndrome
por: Scaglione, Marco, et al.
Publicado: (2019)

General anaesthesia for insertion of an automated implantable cardioverter defibrillator in a child with Brugada and autism
por: Goraksha, Shwetal, et al.
Publicado: (2010)

Brugada Syndrome: The Role of Risk Stratification in Selecting Patients for Implantable Cardioverter-defibrillator Placement
por: Mankbadi, Michael, et al.
Publicado: (2018)

Patient characteristics and in‐hospital complications of subcutaneous implantable cardioverter‐defibrillator for Brugada syndrome in Japan
por: Kawamura, Iwanari, et al.
Publicado: (2019)

Multiple arterial aneurysms coexisting with giant right coronary artery aneurysm: an easy diagnosis by non-invasive imaging methods
por: Bouratzis, Vasileios, et al.
Publicado: (2023)

Ascending aorta thrombosis in a patient with COVID-19 who was already receiving anticoagulation therapy
por: Bouratzis, Vasileios, et al.
Publicado: (2023)

Concomitant Brugada syndrome substrate ablation and epicardial abdominal cardioverter-defibrillator implantation in a child
por: de Asmundis, Carlo, et al.
Publicado: (2018)

Outcomes in Brugada Syndrome Patients With Implantable Cardioverter-Defibrillators: Insights From the SGLT2 Registry
por: Lee, Sharen, et al.
Publicado: (2020)

Implantable cardioverter-defibrillators /
Publicado: (1994)

Two Cases of Arrhythmic Mitral Valve Prolapse: Evil Has Many Faces
por: Sfairopoulos, Dimitrios, et al.
Publicado: (2022)

Congenital Myotonic Dystrophy and Brugada Syndrome: A Report of Two Cases
por: Gupta, Kunal, et al.
Publicado: (2020)

Differences in the Profile of Circulating Immune Cell Subsets in Males with Type 2 Cardiorenal Syndrome versus CKD Patients without Established Cardiovascular Disease
por: Duni, Anila, et al.
Publicado: (2023)

Deactivation of implantable cardioverter-defibrillators
por: Wan, Darryl, et al.
Publicado: (2021)

Implantation of Implantable Cardioverter Defibrillators in Kazakhstan
por: Begisbayev, Temirkhan, et al.
Publicado: (2022)

The subcutaneous implantable cardioverter-defibrillator should be considered for all patients with an implantable cardioverter-defibrillator indication
por: Tan, Jian Liang, et al.
Publicado: (2022)

The Role of Myocardial Perfusion Imaging in the Prediction of Major Adverse Cardiovascular Events at 1 Year Follow-Up: A Single Center’s Experience
por: Zotou, Paraskevi, et al.
Publicado: (2023)

Delayed identification of high‐degree atrioventricular block with prolonged asystole revealed after the removal of an implantable loop recorder owing to battery depletion
por: Korantzopoulos, Panagiotis, et al.
Publicado: (2020)

Implantable Cardioverter-Defibrillator for Primary Prevention in Asia
por: Younis, Arwa, et al.
Publicado: (2023)

T-wave oversensing during drug challenge test after subcutaneous implantable cardioverter-defibrillator implantation in a patient with Brugada syndrome
por: Kamakura, Tsukasa, et al.
Publicado: (2016)

Pectoralis blocks for insertion of an implantable cardioverter defibrillator in two patients with Duchenne muscular dystrophy
por: Froyshteter, Alexander B., et al.
Publicado: (2018)

Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator
por: Jazayeri, Mohammad-Ali, et al.
Publicado: (2017)

Relation of multicenter automatic defibrillator implantation trial implantable cardioverter-defibrillator score with long-term cardiovascular events in patients with implantable cardioverter-defibrillator
por: Uslu, Abdulkadir, et al.
Publicado: (2018)

Refractoriness to subcutaneous implantable cardioverter defibrillator after frequent therapies for ventricular fibrillation storms in a Brugada syndrome case
por: Nakao, Yasuhisa, et al.
Publicado: (2020)

Dutch Outcome in Implantable Cardioverter‐Defibrillator Therapy: Implantable Cardioverter‐Defibrillator–Related Complications in a Contemporary Primary Prevention Cohort
por: van Barreveld, Marit, et al.
Publicado: (2021)

Remote Monitoring of Implantable Cardioverter Defibrillator
por: Reynolds, Dwight W, et al.
Publicado: (2006)

The Subcutaneous Implantable Cardioverter-Defibrillator: Not For All
por: Nair, Krishnakumar, et al.
Publicado: (2014)

Programming implantable cardioverter/defibrillators and outcomes
por: Horlbeck, Fritz W., et al.
Publicado: (2015)

Implantable cardioverter–defibrillator in hypertrophic cardiomyopathy
por: Sanchez, Diego Jimenez, et al.
Publicado: (2018)

Characteristics of Cardiac Memory in Patients with Implanted Cardioverter-defibrillators: The Cardiac Memory with Implantable Cardioverter-defibrillator (CAMI) Study
por: Haq, Kazi T., et al.
Publicado: (2021)

Pause-prevention pacing in an extravascular implantable cardioverter-defibrillator
por: Sagi, Venkata, et al.
Publicado: (2023)

Defibrillation Testing of the Implantable Cardioverter Defibrillator: When, How, and by Whom?
por: Pires, Luis A
Publicado: (2007)

Predictors of Elevated Defibrillation Threshold with the Subcutaneous Implantable Cardioverter-defibrillator
por: Do, Khuyen, et al.
Publicado: (2017)

A sustained ventricular tachycardia overlooked by subcutaneous implantable cardioverter-defibrillator but recognized by co-implanted transvenous implantable cardioverter defibrillator
por: Goto, Kentaro, et al.
Publicado: (2020)

Impairment of Quality of Life in Patients with Implanted Subcutaneous Cardioverter Defibrillator (S-ICD) Compared to Implanted Transvenous Cardioverter Defibrillator Therapy
por: Thienel, Manuela, et al.
Publicado: (2022)

Mid-term follow-up of patients with Brugada syndrome following a cardioverter defibrillator implantation: A single center experience
por: Kharazi, A, et al.
Publicado: (2007)

Intrapericardial Implantation of an Implantable Cardioverter-Defibrillator in a Child
por: Seong, Yong Won, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_00fupf2i9itrdcgp7mqjfricu8